Daan C H van Dorst

4PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 25, 2025
Onset and progression of atherosclerosis in patients with melanoma treated with immune checkpoint inhibitors.

Daan C H van Dorst, Tom J J Uyl, Astrid A M Van der Veldt

|Dec 30, 2022
Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor-Induced Blood Pressure Rise: A Clinical Cohort Study.

Daan C H van Dorst, Sumeyye Kabadayi, Esther Oomen-de Hoop

|Apr 20, 2022
Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage.

Katrina M Mirabito Colafella, Daan C H van Dorst, Rugina I Neuman

|Jul 20, 2021
Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?

Daan C H van Dorst, Leni van Doorn, Katrina M Mirabito Colafella

Pageof 1

Frequent Collaborators

3 joint publications

A H Jan Danser

2 joint publications

Ron H J Mathijssen

1 joint publications

Karla Bianca Neves

1 joint publications

Augusto C Montezano